Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants

  • Carmen D. Zorrilla
  • , Russell Van Dyke
  • , Arlene Bardeguez
  • , Edward P. Acosta
  • , Betsy Smith
  • , Michael D. Hughes
  • , Sharon Huang
  • , D. Heather Watts
  • , Barbara Heckman
  • , Eleanor Jiménez
  • , George McSherry
  • , Lynne Mofenson

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Saquinavir boosted with low-dose ritonavir given with zidovudine and lamivudine was well tolerated by pregnant women and their infants. All mothers had <400 human immunodeficiency virus type 1 RNA copies/ml at delivery. Two had elevated liver transaminases and amylase. Seven infant adverse events were possibly treatment related (anemia, neutropenia, and hyperbilirubinemia).

Original languageEnglish (US)
Pages (from-to)2208-2210
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume51
Issue number6
DOIs
StatePublished - Jun 2007

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants'. Together they form a unique fingerprint.

Cite this